{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:34:24Z","timestamp":1759937664316},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammopharmacology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1163\/156856004773121392","type":"journal-article","created":{"date-parts":[[2004,3,14]],"date-time":"2004-03-14T02:08:55Z","timestamp":1079230135000},"page":"81-88","source":"Crossref","is-referenced-by-count":4,"title":["Time-course evaluation of whole blood phagocytosis in mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"],"prefix":"10.1007","volume":"12","author":[{"given":"Haseeb Ahmad","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"vsp_09254692_v12n1_s7_CR1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-0987(00)00170-6","volume":"12","author":"T. Araki","year":"2001","unstructured":"Araki, T., Mikami, T., Tanji, H., et al. (2001). Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-treated mouse, Eur. J. Pharm. Sci. 12, 231\u2013238.","journal-title":"Eur. J. Pharm. Sci."},{"key":"vsp_09254692_v12n1_s7_CR2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","volume":"71","author":"N. Aubin","year":"1998","unstructured":"Aubin, N., Curet, O., Deffois, A., et al. (1998). Aspirin and salicylate protects against MPTP-induced dopamine depletion in mice, J. Neurochem. 71, 1635\u20131642.","journal-title":"J. Neurochem."},{"key":"vsp_09254692_v12n1_s7_CR3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","volume":"35","author":"P. A. Ballard","year":"1985","unstructured":"Ballard, P. A., Tetrud, J. W. and Langston, J. W. (1985). Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP): seven cases, Neurology 35, 949\u2013956.","journal-title":"Neurology"},{"key":"vsp_09254692_v12n1_s7_CR4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0162-3109(96)00140-3","volume":"35","author":"K. Bieganowska","year":"1996","unstructured":"Bieganowska, K., Czonkowska, A. and Korlak, J. (1996). Pargyline pretreatment prevents immuno-logical changes induced by MPTP in mice, Immunopharmacology 35, 149\u2013154.","journal-title":"Immunopharmacology"},{"key":"vsp_09254692_v12n1_s7_CR5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0006-291X(85)90631-X","volume":"126","author":"E. P. Brestel","year":"1985","unstructured":"Brestel, E. P. (1985). Co-oxidation of luminol by hypochloriteand hydrogen peroxide. Implication forneutrophil chemiluminescence, Biochem. Biophys. Res. Commu 126, 482\u2013488.","journal-title":"Biochem. Biophys. Res. Commu"},{"key":"vsp_09254692_v12n1_s7_CR6","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.4049\/jimmunol.130.5.2324","volume":"130","author":"K. Cheung","year":"1983","unstructured":"Cheung, K., Archibald, A. C. and Robinson, M. F. (1983). The origin of chemiluminescence produced by neutrophils stimulated by opsonized zymosan, J. Immunol. 130, 2324\u20132329.","journal-title":"J. Immunol."},{"key":"vsp_09254692_v12n1_s7_CR7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0192-0561(92)90070-2","volume":"14","author":"D. S. Chi","year":"1992","unstructured":"Chi, D. S., Gong, L., Diagneault, E. A., et al. (1992). Effects of MPTP and vitamin E treatments on immune function in mice, Int. J. Immunopharmacol. 14, 739\u2013746.","journal-title":"Int. J. Immunopharmacol."},{"key":"vsp_09254692_v12n1_s7_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1191\/096032701678227695","volume":"20","author":"M. Gauthier","year":"2001","unstructured":"Gauthier, M. and Girard, D. (2001). Activation of human neutrophils by chlordane: induction of superoxide production and phagocytosis but not chemotaxis and apoptosis, Human Exp. Toxicol. 20, 229\u2013235.","journal-title":"Human Exp. Toxicol."},{"key":"vsp_09254692_v12n1_s7_CR9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/clim.2000.4946","volume":"98","author":"M. Gauthier","year":"2001","unstructured":"Gauthier, M., Roberge, C. J., Pelletier, M., et al. (2001). Activation of human neutrophils by technical toxaphene, Clin. Immunol. 98, 46\u201353.","journal-title":"Clin. Immunol."},{"key":"vsp_09254692_v12n1_s7_CR10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","volume":"311","author":"R. E. Heikkila","year":"1984","unstructured":"Heikkila, R. E., Manzino, L., Cabbat, F. S., et al. (1984). Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors, Nature 311, 467\u2013469.","journal-title":"Nature"},{"key":"vsp_09254692_v12n1_s7_CR11","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1046\/j.1471-4159.1998.71062634.x","volume":"71","author":"P. Klivenyi","year":"1998","unstructured":"Klivenyi, P., Beal, M. F., Ferrante, R. J., et al. (1998). Mice defficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity, J. Neurochem. 71, 2634\u20132637.","journal-title":"J. Neurochem."},{"key":"vsp_09254692_v12n1_s7_CR12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","volume":"39","author":"M. Kohutnicka","year":"1998","unstructured":"Kohutnicka, M., Lewandowska, E., Kurkowska-Jastrzebska, I., et al. (1998). Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP), Immunopharmacology 39, 167\u2013180.","journal-title":"Immunopharmacology"},{"key":"vsp_09254692_v12n1_s7_CR13","first-page":"1041","volume":"130","author":"N. A. Krupina","year":"2000","unstructured":"Krupina, N. A., Davydova, T. V., Fomina, V. G., et al. (2000). Count and phagocytic activity of leukocytes in rats with experimental depressive syndrome caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Bull. Exp. Biol. Med. 130, 1041\u20131044.","journal-title":"Bull. Exp. Biol. Med."},{"key":"vsp_09254692_v12n1_s7_CR14","first-page":"1","volume":"59","author":"I. Kurkowska-Jastrzebska","year":"1999","unstructured":"Kurkowska-Jastrzebska, I., Wronska, A., Kohutnicka, M., et al. (1999). The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse, Exp. Neurol. 59, 1\u20138.","journal-title":"Exp. Neurol."},{"key":"vsp_09254692_v12n1_s7_CR15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1567-5769(02)00078-4","volume":"2","author":"I. Kurkowska-Jastrzebska","year":"2002","unstructured":"Kurkowska-Jastrzebska, I., Babiuch, M., Joniec, I., et al. (2002). Indomethacin protects against neurodegenerationcaused by MPTP intoxication in mice, Int. Immunopharmacol. 2, 1213\u20131218.","journal-title":"Int. Immunopharmacol."},{"key":"vsp_09254692_v12n1_s7_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(84)90293-3","volume":"48","author":"J. W. Langston","year":"1984","unstructured":"Langston, J. W., Irwin, I., Langston, E. B., et al. (1984). 1-Methyl-4-phenyl-pyridinium ion (MPPC): identification of a metabolite of MPTP, a toxin to the substantia nigra, Neurosci. Lett. 48, 87\u201392.","journal-title":"Neurosci. Lett."},{"key":"vsp_09254692_v12n1_s7_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-079x.2002.10831.x","volume":"32","author":"X. J. Li","year":"2002","unstructured":"Li, X. J., Gu, J., Lu, S. D., et al. (2002). Melatonin attenuates MPTP-induced dopaminergic neuronal injury associated with scavenging hydroxyl radical, J. Pineal Res. 32, 47\u201352.","journal-title":"J. Pineal Res."},{"key":"vsp_09254692_v12n1_s7_CR18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-0102(98)00077-7","volume":"32","author":"Y. B. Li","year":"1998","unstructured":"Li, Y. B., Kaur, C. and Ling, E. A. (1998). Neuronal degeneration and microglial reaction in the fetal and postnatal rat brain after transient maternal hypoxia, Neurosci. Res. 32, 137\u2013148.","journal-title":"Neurosci. Res."},{"key":"vsp_09254692_v12n1_s7_CR19","first-page":"401","volume-title":"Analytical Applications of Bioluminescence and Chemilumines-cence","author":"E. Lilius","year":"1984","unstructured":"Lilius, E. and Waris, M. (1984). A very sensitive and rapid chemiluminescence method for the mea-surement of phagocytosis, in: Analytical Applications of Bioluminescence and Chemilumines-cence, L. J. Kricka, P. E. Stanley, G. H. G. Thorpe and T. P. Whitehead (Eds), pp. 401\u2013404. Academic Press, New York, NY."},{"key":"vsp_09254692_v12n1_s7_CR20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1023\/A:1020989812576","volume":"27","author":"S. Mandel","year":"2002","unstructured":"Mandel, S., Grunblatt, E., Maor, G., et al. (2002). Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray, Neurochem. Res. 27, 1231\u20131243.","journal-title":"Neurochem. Res."},{"key":"vsp_09254692_v12n1_s7_CR21","first-page":"80","volume":"1","author":"T. N. Maslova","year":"1975","unstructured":"Maslova, T. N. and Dunaeva, V. V. (1975). Effect of monoamine oxidase inhibitors on the phagocytic activity of macrophages, Zh. Mikrobiol. Epidemiol. Immunobiol. 1, 80\u201385.","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"key":"vsp_09254692_v12n1_s7_CR22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/bj2610293","volume":"261","author":"T. B. McCall","year":"1989","unstructured":"McCall, T. B., Boughton-Smith, N. K., Palmer, R. M. J., et al. (1989). Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion, Biochem. J. 261, 293\u2013296.","journal-title":"Biochem. J."},{"key":"vsp_09254692_v12n1_s7_CR23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ana.410320703","volume":"32","author":"C. W. Olanow","year":"1992","unstructured":"Olanow, C. W. (1992). An introduction to the free radical hypothesis in Parkinson's disease, Ann. Neurol. 32, 52\u201359.","journal-title":"Ann. Neurol."},{"key":"vsp_09254692_v12n1_s7_CR24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1179\/135100099101535124","volume":"4","author":"M. M. Oosthuizen","year":"1999","unstructured":"Oosthuizen, M. M. and Greyling, D. (1999). Antioxidants suitable for use with chemiluminescence to identify oxyradical species, Redox Rep. 4, 277\u2013290.","journal-title":"Redox Rep."},{"key":"vsp_09254692_v12n1_s7_CR25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/em.10133","volume":"41","author":"G. G. Ortiz","year":"2003","unstructured":"Ortiz, G. G., Zuniga-Gonzalez, G., Garcia, J. J., et al. (2003). 1-Methyl-4-phenyl-1,2,3,6-tetrahydro-pyridineinducedlipid peroxidation and DNA damage in mouse bone marrow and blood, Environ. Mol. Mutagen. 41, 64\u201368.","journal-title":"Environ. Mol. Mutagen."},{"key":"vsp_09254692_v12n1_s7_CR26","first-page":"699","volume":"39","author":"M. M. Potselueva","year":"1997","unstructured":"Potselueva, M. M., Marinov, B. S., Pustovidko, A. V., et al. (1997). The effect of catecholamines on the luminol-dependent chemiluminescence of rat polymorphonuclear leukocytes, Tsitologiia 39, 699\u2013704.","journal-title":"Tsitologiia"},{"key":"vsp_09254692_v12n1_s7_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0167-4838(89)90066-6","volume":"994","author":"R. A. Radi","year":"1989","unstructured":"Radi, R. A., Rubbo, H. and Prodanov, E. (1989). Comparison of the effects of superoxide dismutase and cytochrome c on luminol chemiluminescence produced by xanthine oxidase-catalysed reac-tions, Biochim. Biophys. Acta. 994, 89\u201393.","journal-title":"Biochim. Biophys. Acta."},{"key":"vsp_09254692_v12n1_s7_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bj2900051","volume":"290","author":"R. Radi","year":"1993","unstructured":"Radi, R., Cosgrove, T. P., Beckman, J. S., et al. (1993). Peroxynitrile-inducedluminol chemilumines-cence, Biochem. J. 290, 51\u201357.","journal-title":"Biochem. J."},{"key":"vsp_09254692_v12n1_s7_CR29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0024-3205(89)90374-3","volume":"44","author":"G. Renoux","year":"1989","unstructured":"Renoux, G., Biziere, K., Renoux, M., et al. (1989). Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune response in mice, Life Sci. 44, 771\u2013777.","journal-title":"Life Sci."},{"key":"vsp_09254692_v12n1_s7_CR30","first-page":"581","volume":"62","author":"P. J. Roberts","year":"1987","unstructured":"Roberts, P. J. and Segal, A. W. (1987). The digestion of bacterial macromolecules by phagocytic cells: the effect of mepacrine and ethanol, Immunology 62, 581\u2013586.","journal-title":"Immunology"},{"key":"vsp_09254692_v12n1_s7_CR31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0753-3322(99)80080-8","volume":"53","author":"H. Salman","year":"1999","unstructured":"Salman, H., Bergman, M., Djaldetti, R., et al. (1999). Decreased phagocytic function in patients with Parkinson's disease, Biomed. Pharmacother. 53, 146\u2013148.","journal-title":"Biomed. Pharmacother."},{"key":"vsp_09254692_v12n1_s7_CR32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0006-8993(98)00790-2","volume":"809","author":"T. A. Seaton","year":"1998","unstructured":"Seaton, T. A., Cooper, J. M. and Schapira, A. H. (1998). Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins, Brain Res. 809, 12\u201317.","journal-title":"Brain Res."},{"key":"vsp_09254692_v12n1_s7_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1987.tb03384.x","volume":"49","author":"T. P. Singer","year":"1987","unstructured":"Singer, T. P., Castagnoli Jr., N., Ramsay, R. R., et al. (1987). Biochemical events in the development of parkinsonisminduced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP), J. Neurochem. 49, 1\u20138.","journal-title":"J. Neurochem."},{"key":"vsp_09254692_v12n1_s7_CR34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0039-6060(99)70171-6","volume":"126","author":"S. Sookhai","year":"1999","unstructured":"Sookhai, S., Wang, J. H., McCourt, M., et al. (1999). Dopamine induces neutrophil apoptosis through a dopamine D-1 receptor-independentmechanism, Surgery 126, 314\u2013322.","journal-title":"Surgery"},{"key":"vsp_09254692_v12n1_s7_CR35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0361-9230(88)90240-7","volume":"21","author":"E. Sundstrom","year":"1988","unstructured":"Sundstrom, E., Luthman, J., Goldstein, M., et al. (1988). Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL\/ 6 mice, Brain Res. Bull. 21, 257\u2013263.","journal-title":"Brain Res. Bull."},{"key":"vsp_09254692_v12n1_s7_CR36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1353-8020(98)00007-8","volume":"4","author":"M. Tariq","year":"1998","unstructured":"Tariq, M., Khan, H.A., Al Moutaery, K., et al. (1998). Dipyridamole potentiates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced experimental parkinsonism in mice, Parkin. Relat. Disord. 4, 43\u201350.","journal-title":"Parkin. Relat. Disord."},{"key":"vsp_09254692_v12n1_s7_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0361-9230(00)00427-5","volume":"54","author":"M. Tariq","year":"2001","unstructured":"Tariq, M., Khan, H. A., Al Moutaery, K., et al. (2001). Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of parkinsonism in rodents. Brain Res. Bull. 54, 77\u201382.","journal-title":"Brain Res. Bull."},{"key":"vsp_09254692_v12n1_s7_CR38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/8755-9668(85)90010-9","volume":"1","author":"A. I. Tauber","year":"1985","unstructured":"Tauber, A. I. and Babior, B. M. (1985). Neutrophil oxygen reduction: the enzymes and the products, Free Radic. Biol. Med. 1, 265\u2013307.","journal-title":"Free Radic. Biol. Med."},{"key":"vsp_09254692_v12n1_s7_CR39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.10332","volume":"18","author":"P. Teismann","year":"2003","unstructured":"Teismann, P., Tieu, K., Cohen, O., et al. (2003). Pathogenic role of glial cells in Parkinson's disease, Mov. Disord. 18, 121\u2013129.","journal-title":"Mov. Disord."},{"key":"vsp_09254692_v12n1_s7_CR40","first-page":"311","volume":"87","author":"S. P. Thorat","year":"1994","unstructured":"Thorat, S. P., Thatte, U. M., Pai, N., et al. (1994). Inhibition of phagocytes by cyclosporin in vitro, Q. J. Med. 87, 311\u2013314.","journal-title":"Q. J. Med."},{"key":"vsp_09254692_v12n1_s7_CR41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/CDLI.3.4.423-428.1996","volume":"3","author":"C. Wenisch","year":"1996","unstructured":"Wenisch, C., Parschalk, B., Weiss, A., et al. (1996). High-dose catecholamine treatment decreases polymorphonuclear leukocyte phagocytic capacity and reactive oxygen production, Clin. Diagn. Lab. Immunol. 3, 423\u2013428.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"vsp_09254692_v12n1_s7_CR42","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","volume":"100","author":"D. C. Wu","year":"2003","unstructured":"Wu, D. C., Teismann, P., Tieu, K., et al. (2003). NADPH oxidase mediates oxidative stress in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease, Proc. Natl. Acad. Sci. USA 100, 6145\u20136150.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"vsp_09254692_v12n1_s7_CR43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(00)00853-3","volume":"281","author":"L. Zou","year":"2000","unstructured":"Zou, L., Xu, J., Jankovic, J., et al. (2000). Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinein C57BL\/6 mice, Neurosci. Lett. 281, 167\u2013170.","journal-title":"Neurosci. Lett."}],"container-title":["InflammoPharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1163\/156856004773121392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T03:33:44Z","timestamp":1682652824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1163\/156856004773121392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["vsp_09254692_v12n1_s7"],"URL":"https:\/\/doi.org\/10.1163\/156856004773121392","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}